BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Relmada Therapeutics to Present at the Biotech Showcase 2013


1/4/2013 6:59:02 AM

BLUE BELL, Pa., Jan. 4, 2013 /PRNewswire/ -- Relmada Therapeutics, a clinical-stage company developing novel therapies for the treatment of chronic pain, today announced that Sergio Traversa, the company's Chief Executive Officer, will be presenting at the Biotech Showcase in San Francisco on Tuesday, January 8, 2013 at 1:45 PM Pacific Time.

The presentation will include an overview of Relmada business and an update on the ongoing development programs of LevoCap, d-methadone, MepiGel and BuTab for the treatment of various forms of chronic pain.

The Biotech Showcase is being held at the Parc 55 Wyndham Union Square Hotel in San Francisco and it provides private and public life science companies the opportunity to present to an audience of investors and business development executives.

About Relmada Therapeutics

Relmada Therapeutics, Inc. is a clinical stage, private biopharmaceutical company focused on developing both novel versions of proven drugs and new molecules that potentially address high unmet medical needs in the treatment of chronic pain. The Company has a deep and diversified portfolio of four lead productsat different stages of development and an early stage pipeline of an additional three products. Our executive offices are located at 138 Canterbury Lane, Blue Bell, PA 19422 and our phone number is 917 405 1305.

Visit our website at www.relmada.com

SOURCE Relmada Therapeutics, Inc.



Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES